Cardiovascular Acquisition Analysis

A multinational pharmaceutical and medical device company targeted a potential acquisition to provide it with an important strategic position in the cardiovascular market. Analysis Group assembled a world-class panel of clinical experts to explore both the potential applications and the limitations of the target company’s products. Our analysis revealed that the acquisition target had not fully exploited market opportunities and had predicted unrealistic revenues by underestimating the competition and pricing trends. Our analysis ultimately showed that despite these issues, anticipated revenues were still strong.